Press release content from Globe Newswire. The AP news staff was not involved in its creation.
NEW YORK, Nov. 26, 2020 (GLOBE NEWSWIRE) — Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Biogen Inc. (NASDAQ: BIIB) between October 22, 2019 and November 6, 2020, inclusive (the “Class Period”).
To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=biogen-inc&id=2484 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email [email protected] for information on the class action.
If you wish to serve as lead plaintiff, you must move the Court before the January 12, 2021 DEADLINE. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: the larger dataset did not provide